Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

How Does Sarclisa Work in Multiple Myeloma? Sarclisa is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by targeting a specific ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

DVRd therapy significantly improves MRD negativity and PFS, showing potential as a frontline treatment for NDMM patients who are transplant-ineligible or deferred. The CEPHEUS trial highlights DVRd's ...

The author challenges the terms "caregiver" and "incurable," suggesting more hopeful alternatives like "Lovegiver" and "can be" or "will be." Advances in multiple myeloma treatments have allowed ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Joseph Mikhael, MD ...

Eva Patten talks about living with her multiple myeloma and amyloidosis diagnoses 18 years after first hearing the news ...